2018 annual financial data

Tenax Therapeutics, Inc. 2018 Operating margin

Tenax Therapeutics, Inc. 2018 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -6,893,280 USD and net income was -6,813,445 USD.
Operating cash flow was -5,499,461 USD.

Get free Tenax Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-6,893,280 USD
Net income
-6,813,445 USD
Operating cash flow
-5,499,461 USD